U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528014) titled 'ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1' on April 07.
Brief Summary: This study will evaluate the feasibility and clinical utility of developing predictive models of treatment response for patients with depressed mood using multimodal clinical data collected in real-world clinical settings. The study will examine outcomes among patients treated with interventions including esketamine, conventional transcranial magnetic stimulation (TMS), or Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). Retrospective clinical and research data from existing databases may also be incorporated, when available...